Empowering providers to manage medication costs effectively

Take control of skyrocketing medication costs and improve patient outcomes with CuraFi.

Talk With an Expert

Mitigate drug risk

The IRA has inflated financial risk for providers due to potential increases in Part D drug spending. New high-cost Part B drugs are increasing expenses for ACOs and other risk-bearing organizations. CuraFi's proprietary analytics engine and expert healthcare team can help you optimize your risk and savings across Part B and Part D spend.

Decorative Shapes

Real-time intelligence to lower the cost of care

Our extensive database provides unparalleled insights into specialty drug usage and costs. With CuraFi, you can:

  • Build pricing models that accurately determine financial risk
    Build pricing models that accurately determine financial risk
  • B Make informed decisions that positively impact patient care
    Make informed decisions that positively impact patient care
  • BOperationalize cost management strategies
    Operationalize cost management strategies
  • Enable value-based care models
    Enable value-based care models

Clinically validated to lower Part B drug costs

Enter # of ACO beneficiaries:

Potential savings:

$2,809,182

Unmanaged

Unmanaged Risk

$4.7M

ACO Risk

CuraFi Managed

CuraFi Managed Risk

$1.9M

ACO Risk

Curafi LogoCurafi Circle

Learn how CuraFi can help

Reach out today to see how your organization can benefit from CuraFi's drug risk and cost management solution.